Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
»
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily Briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All Stock Picks
Subscribe
Portfolios
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Undervalued stocks
ESG stocks
Momentum stocks
Yield stocks
Quality stocks
Growth stocks
Investment Themes
The SPAC
The Golden Age of Video Games
Strategic Metals
Moat
The future of mobility
uranium
Rankings
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment Themes
The SPAC
The Golden Age of Video Games
Strategic Metals
Moat
The future of mobility
uranium
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Apprendre la bourse
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Ocular Therapeutix, Inc.
News
Analyst Reco.
OCUL
US67576A1007
OCULAR THERAPEUTIX, INC.
(OCUL)
Add to my list
Report
Delayed Nasdaq -
05/17 04:00:01 pm
3.77
USD
+12.20%
05/11
Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy Rating
MT
05/10
Ocular therapeutix reports first quarter 2022 financial results and business update
AQ
05/10
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Buy Rating
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Analyst Recommendations on OCULAR THERAPEUTIX, INC.
05/11
Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy R..
MT
05/10
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Bu..
MT
05/10
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $16 From $20, Reiterates Ov..
MT
03/01
JMP Securities Adjusts Ocular Therapeutix's Price Target to $22 from $30, Keeps Market ..
MT
2021
Berenberg Bank Adjusts Price Target on Ocular Therapeutix to $23 From $26, Maintains Bu..
MT
2021
JMP Securities Adjusts Price Target on Ocular Therapeutix to $30 From $27, Maintains Ma..
MT
2021
OCULAR THERAPEUTIX
: Piper Sandler Adjusts Price Target on Ocular Therapeutix to $20 From ..
MT
2021
OCULAR THERAPEUTIX
: HC Wainwright Adjusts Price Target on Ocular Therapeutix to $14 From ..
MT
2021
OCULAR THERAPEUTIX
: Raymond James Adjusts Price Target on Ocular Therapeutix to $29 From ..
MT
2021
OCULAR THERAPEUTIX
: HC Wainwright Adjusts Ocular Therapeutix's Price Target to $18 from $..
MT
2021
OCULAR THERAPEUTIX
: JMP Securities Adjusts Ocular Therapeutix's Price Target to $33 from ..
MT
2021
OCULAR THERAPEUTIX
: HC Wainwright Upgrades Ocular Therapeutix to Buy From Neutral; Price ..
MT
2021
OCULAR THERAPEUTIX
: Berenberg Bank Adjusts Ocular Therapeutix PT to $26 From $27, Maintai..
MT
2020
OCULAR THERAPEUTIX
: JMP Securities Adjusts Ocular Therapeutix's Price Target to $30 From ..
MT
2020
OCULAR THERAPEUTIX
: HC Wainwright Downgrades Ocular Therapeutix to Neutral From Buy
MT
2020
OCULAR THERAPEUTIX
: Berenberg Bank Initiates Coverage on Ocular Therapeutix With Buy Rati..
MT
2020
OCULAR THERAPEUTIX
: HC Wainwright Adjusts Ocular Therapeutix's Price Target to $14 From $..
MT
Upcoming event on OCULAR THERAPEUTIX, INC.
05/16/22
American Society of Gene and Cell Therapy Conference - Poster No. M-167
Company calendar
Upcoming sector events
07/19/22
JOHNSON & JOHNSON
: Interim 2022 Earnings Release
07/21/22
ROCHE HOLDING AG
: Interim 2022 Earnings Release
07/29/22
ABBVIE INC.
: Interim 2022 Earnings Release (Projected)
08/02/22
PFIZER INC.
: Interim 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals
Master